Fiche publication
Date publication
juillet 2026
Journal
Clinical and public health guidelines
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry
Tous les auteurs :
Leeuwenburgh LC, Holze M, Akhoundzadeh D, Alsourani A, Jimenez RA, Andel PCM, van Houweninge CB, Balduzzi A, Bruna CL, Casciani F, Cattelani A, van Diepen AE, Driessens H, Droogh DHM, Fritzsche JA, van Gansewinkel E, Genova L, Gehrels AM, Dueñas GG, Guastella R, Hoeijmakers LSM, Hoogteijling TJ, Javed AA, Aktas BK, Kinny-Köster B, Lamoré A, Seng Liem K, Lionetto G, Faro LL, Lutter L, Mastronardi M, Maurer CH, Montorsi R, Musa J, Rompen IF, Scheepens JCM, Sochorová D, Stoop TF, Tezcan N, Uijterwijk BA, Vella R, Vernuccio F, Voermans RP, Hilal MA, Adsay V, Algül H, Ambrosini V, Archibugi L, Backman E, Barbu ST, Boggi U, Borge-Andersen C, Burgdorf SK, Clarkson A, van Cutsem E, Cuyle PJ, Daamen LA, Rosa P, den Dulk M, de Los Rios CD, Drury A, Esposito I, Everett SM, Sarasqueta AF, Frigerio I, Koerkamp BG, Hackert T, Huguet F, Kartalis N, Letsch A, Langenberg P, Levett D, Liposits G, Malats N, van Malenstein H, Malleo G, Maravic Z, Marchegiani G, Martins A, Meijerink MR, Michalski CW, Mieog JSD, Moka E, Mukherjee S, Nanni C, Orsi F, Papamichael D, Partelli S, Payne C, Pergolini I, Radenkovic D, Roberts KJ, Salvia R, Sauvanet A, Scorsetti M, Seebo M, Seufferlein T, Stättner S, Vanbiervliet G, Verbeke CS, Volk T, Werner J, Wilmink JW, Zins M, Conroy T, Pfeiffer P, Ducreux M, Ali M, Langendam M, Vali Y, Rangelova EB, Besselink MG,
Lien Pubmed
Résumé
Pancreatic cancer remains one of the most lethal cancers despite extensive efforts and research conducted over the past decades. To effectuate groundbreaking improvements in pancreatic cancer treatment, interdisciplinary and international collaboration is essential. Evidence-based guidelines, including state-of-the-art evidence and expert opinion, are crucial to guide medical specialists, researchers, and patients, especially on issues where consensus is still lacking. This article describes the methodological protocol for the development of the European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer. The guideline aims to identify current knowledge gaps on pancreatic cancer management, develop questions based on these knowledge gaps, and answer these questions with evidence-based recommendations supplemented, when evidence is lacking, with expert advice for treatment and future research.
Mots clés
PDAC, cancer treatment, guideline, multi‐societal, pancreatic cancer
Référence
Clin Public Health Guidel. 2026 07;3(3):e70074